ORMP Competitors
Oramed Pharmaceuticals Inc.
$4.20
-$0.17(-3.89%)
49
Overall
80
Value
20
Tech
47
Quality
Market Cap
$181.78M
Volume
166.46K
52W Range
$2.09 - $5.47
Target Price
$7.00
ORMP competitors: RARE, CGEN, SNY, NVO, LXRX. Oramed Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ORMP Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical Inc. | $15.29 | $1.47B | $-3.96 | - | 39 |
| CGEN Compugen Ltd. | $2.10 | $203.36M | $-0.28 | - | 55 |
| SNY Sanofi | $40.23 | $98.04B | $5.07 | 6.01% | 57 |
| NVO Novo Nordisk A/S | $38.18 | $169.41B | $3.53 | 4.86% | 47 |
| LXRX Lexicon Pharmaceuticals, Inc. | $1.77 | $783.12M | $-0.17 | - | 41 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORMP | $4.20 | -3.9% | 166.46K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oramed Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW